glp-1/gip dual agonist weight loss supplement Top GLP-1 Agonists Balance Efficacy, Safety GLP-1 Medications: Everything You Need

In the ATTAIN-1 Phase 3 trial, the most frequently reported adverse events with orforglipron 36 mg versus placebo were nausea (33.7% vs 10.4%), constipation (25.4% vs 9.3%), diarrhea (23.1% vs 9.6%), and vomiting (24.0% vs 4.0%)

Europe: 2006), several pharmaceutical companies started diverse developments aiming at GLP-1 receptor stimulation with greater effectiveness and longer duration of action

As of March 2025, 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs

This adaptive pattern triggers systemic adjustments in energy metabolism, encompassing glucose homeostasis, hormonal secretion, energy substrate utilization, and energy expenditure regulation

The precise mechanisms underlying the ocular benefits of GLP-1RAs remain incompletely elucidated

Examples include semaglutide (brand names Ozempic and Wegovy), tirzepatide (brand name Mounjaro), and liraglutide (brand names Victoza and Saxenda)